PARP1 and Parkinson disease: In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse models of Parkinson’s disease, PARP-1 inhibition and PARP-1/2 knockout improve motor behaviour and prevent dopaminergic neuron loss in the SNpc.16–18